Cardiac function index provided by transpulmonary thermodilution   behaves as an indicator of left ventricular systolic function.
OBJECTIVE
To test whether cardiac function index could actually behave as an indicator of left ventricular systolic function by testing if 1) it increased with inotropic stimulation; 2) it was not altered by fluid loading; 3) it correlated with the echographic left ventricular ejection fraction, considered as the clinical gold standard for measuring left ventricular systolic function, and it reliably tracked the changes in left ventricular ejection fraction during therapeutic intervention. The transpulmonary thermodilution calculates the cardiac function index, which is the ratio of cardiac output over global end-diastolic volume.


METHODS
Prospective study.


METHODS
Medical intensive care unit of a university hospital.


METHODS
Thirty-nine patients (n = 48 cases) with acute circulatory failure.


METHODS
A 500-mL saline administration (n = 24 cases) and a dobutamine infusion (n = 24 cases).


RESULTS
We simultaneously measured left ventricular ejection fraction (monoplane or biplane Simpson method) and cardiac function index at baseline and after saline and dobutamine administration. As volume expansion altered neither left ventricular ejection fraction (47 +/- 11% to 47 +/- 11%) nor cardiac function index (4.5 +/- 2.2 to 4.5 +/- 2.1 min(-1)), dobutamine infusion significantly increased left ventricular ejection fraction by 32 +/- 28% and cardiac function index by 29 +/- 22%. Considering the 96 cardiac function index:left ventricular ejection fraction pairs of measurements, cardiac function index and left ventricular ejection fraction were correlated significantly (r = .67, p < .05). A cardiac function index <3.2 min(-1) predicted a left ventricular ejection fraction of <35% with a sensitivity of 81% and a specificity of 88%. Importantly, the changes in left ventricular ejection fraction and in cardiac function index during fluid and dobutamine administration were correlated significantly (r = .79, p < .05).


CONCLUSIONS
Cardiac function index fulfilled the criteria required from a clinical indicator of left ventricular global systolic function. Thus, it could serve as an easy bedside detection of the alteration in left ventricular ejection fraction that should alert the physician and incite to perform an echocardiography. Furthermore, cardiac function index tracked accurately the effects of an inotropic therapy.
AP-HP, Hôpital de Bicêtre, Service de Réanimation Médicale, Paris-Sud, Le Kremlin-Bicêtre, France.
Julien
J
Jabot
Xavier
X
Monnet
Lamia
L
Bouchra
Denis
D
Chemla
Christian
C
Richard
Jean-Louis
JL
Teboul
D000368:Aged; D001810:Blood Volume / Q000502:physiology; D002302:Cardiac Output / Q000502:physiology*; D002316:Cardiotonic Agents / Q000008:administration & dosage; D003971:Diastole / Q000502:physiology; D004280:Dobutamine / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007362:Intensive Care Units; D008297:Male; D011446:Prospective Studies; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D012965:Sodium Chloride / Q000008:administration & dosage; D013318:Stroke Volume / Q000502:physiology; D013599:Systole / Q000502:physiology*; D013815:Thermodilution; D016277:Ventricular Function, Left / Q000502:physiology*
D002316:Cardiotonic Agents; D004280:Dobutamine; D012965:Sodium Chloride